SG Americas Securities LLC Purchases 195,393 Shares of The Chemours Company $CC

SG Americas Securities LLC grew its position in The Chemours Company (NYSE:CC) by 478.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 236,236 shares of the specialty chemicals company’s stock after purchasing an additional 195,393 shares during the quarter. SG Americas Securities LLC owned about 0.16% of Chemours worth $2,785,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in CC. Wealth Enhancement Advisory Services LLC lifted its holdings in Chemours by 57.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 20,691 shares of the specialty chemicals company’s stock worth $244,000 after purchasing an additional 7,511 shares during the last quarter. Hudson Bay Capital Management LP bought a new position in Chemours during the 3rd quarter worth $1,925,000. Penn Capital Management Company LLC bought a new position in Chemours during the 3rd quarter worth $10,325,000. CIBC Bancorp USA Inc. acquired a new stake in shares of Chemours during the third quarter worth $254,000. Finally, Caitong International Asset Management Co. Ltd bought a new stake in shares of Chemours in the third quarter valued at about $43,000. Institutional investors own 76.26% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on CC. BMO Capital Markets lowered their price target on shares of Chemours from $20.00 to $19.00 and set an “outperform” rating on the stock in a research report on Monday, February 23rd. Morgan Stanley boosted their price objective on shares of Chemours from $15.00 to $17.00 and gave the company an “equal weight” rating in a report on Monday, February 23rd. Mizuho increased their target price on shares of Chemours from $17.00 to $21.00 and gave the stock an “outperform” rating in a research report on Thursday, March 5th. Jefferies Financial Group reaffirmed a “hold” rating and set a $17.00 target price on shares of Chemours in a report on Monday, February 23rd. Finally, Royal Bank Of Canada reiterated an “outperform” rating and issued a $18.00 price target on shares of Chemours in a research note on Friday, January 16th. Five equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, Chemours presently has a consensus rating of “Hold” and a consensus target price of $18.40.

Chemours Price Performance

Shares of NYSE:CC opened at $21.56 on Friday. The firm has a 50 day moving average of $18.58 and a 200-day moving average of $15.29. The Chemours Company has a 12 month low of $9.13 and a 12 month high of $22.43. The company has a current ratio of 1.78, a quick ratio of 0.85 and a debt-to-equity ratio of 16.33. The stock has a market capitalization of $3.24 billion, a PE ratio of -8.69 and a beta of 1.41.

Chemours (NYSE:CC) last posted its quarterly earnings results on Thursday, February 19th. The specialty chemicals company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.04. Chemours had a negative net margin of 6.41% and a positive return on equity of 41.75%. The business had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same quarter last year, the business posted $0.09 EPS. The firm’s revenue for the quarter was down 2.2% on a year-over-year basis. On average, equities research analysts predict that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Friday, February 27th were given a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date was Friday, February 27th. Chemours’s payout ratio is currently -14.11%.

Chemours Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.